Our validation across 4 cohorts showed that as a single cross‐sectional measurement, a concentration of exosomal α‐synuclein above 14 pg/mL consistently distinguishes PD from MSA or PSP + CBS with an AUC of 0.90–0.98. The gene discussed is CBS; the disease is supranuclear palsy, progressive, 1.